JPMorgan Chase & Co’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,535
| Closed | -$12K | – | 5158 |
|
|
2020
Q1 | $12K | Sell |
4,535
-109
| -2% | -$288 | ﹤0.01% | 4436 |
|
|
2019
Q4 | $5K | Buy |
4,644
+8
| +0.2% | +$9 | ﹤0.01% | 4590 |
|
|
2019
Q3 | $8K | Buy |
4,636
+752
| +19% | +$1.3K | ﹤0.01% | 4600 |
|
|
2019
Q2 | $18K | Sell |
3,884
-103,853
| -96% | -$481K | ﹤0.01% | 4547 |
|
|
2019
Q1 | $696K | Buy |
107,737
+98,974
| +1,129% | +$639K | ﹤0.01% | 3202 |
|
|
2018
Q4 | $44K | Buy |
8,763
+7,302
| +500% | +$36.7K | ﹤0.01% | 4313 |
|
|
2018
Q3 | $12K | Sell |
1,461
-54,739
| -97% | -$450K | ﹤0.01% | 4638 |
|
|
2018
Q2 | $708K | Buy |
+56,200
| New | +$708K | ﹤0.01% | 3291 |
|